NCT04011215Completed
Wool Clothing for the Management of Childhood Atopic Dermatitis (DESSINE2)
Determining Effects of Superfine Sheep Wool in INfantile Eczema (DESSINE 2): a Multicentre Randomized Crossover Study
Source: ClinicalTrials.gov · Last updated 25 May 2025
Brief summary (registry, in English)
The study is a sequentially recruited, cross-over-cohort, outpatient-based evaluation of the effectiveness of wool clothing, as compared to standard clothing, in reducing the severity of childhood atopic dermatitis (eczema) over two consecutive six-week periods.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 19 (actual)
- First submitted
- 3 Jul 2019
- Start date
- 23 Sept 2019
- Primary completion date
- 31 Oct 2024
- Lead sponsor
- Murdoch Childrens Research Institute
- Diseases
- Atopic dermatitis (eczema)
- NCT number
- NCT04011215
What you commit to
- Study type: Interventional
- Participants enrolled: 19
- From 23 Sept 2019 to the primary completion date, 31 Oct 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Use of systemic corticosteroids within 6 weeks of study start.
Other illness
- Has a known allergic contact dermatitis to wool or merino wool
- Has unstable eczema defined by an escalation of treatment requirements during the preceding 6 weeks. This would include flares of AD for any reason including infection, food allergy etc.
Other
- Is unable to attend all scheduled visits
- Any medical reason that is considered by the principal investigator to preclude enrolment.
Who the study is looking for
- Is aged between 3 months and 5 years of age at the time of recruitment
- Has moderate to severe eczema as determined by an EASI score of 7 or above at their initial visit
- Has a legally acceptable representative capable of understanding the informed consent document and providing consent on the participants behalf
Age in the registry: 3 months to 5 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Northwestern University, Skin Disease Research Center, Lurie Children's Hospital Coordinator of this site? Confirm its status | Chicago | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.